[Keratoconjunctivitis sicca (KCS) in dogs].
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001766:Blindness / Q000209:etiology / Q000662:veterinary; D016572:Cyclosporine / Q000627:therapeutic use; D004283:Dog Diseases / Q000188:drug therapy / Q000276:immunology* / Q000473:pathology; D004285:Dogs; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007638:Keratoconjunctivitis Sicca / Q000150:complications / Q000188:drug therapy / Q000276:immunology / Q000473:pathology / Q000662:veterinary*; D017211:Treatment Failure; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D007166:Immunosuppressive Agents; D016572:Cyclosporine